Can Placenta Cells Save Severe COVID-19 Patients?

Pluristem CEO Claims Placenta Cell-Therapy Can Rebalance Immune Systems

 
• By Sten Stovall
  
Yaky Yanay
Pluristem CEO Yanay wants to test his product ASAP in COVID-19 patients • Source: Pluristem Therapeutics Inc.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip